Curanex Pharmaceuticals Inc
CURX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002025942
No open-market purchases or sales by Curanex Pharmaceuticals Inc insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $89.0K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Curanex Pharmaceuticals Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −3 vs. Q4 2025
- Shares held
- 327.8K
- −97.4K (−22.9%) vs. Q4 2025
- Total value
- $167.6K
- +$27.1K (+19.3%) vs. Q4 2025
- New holders
- 2
- 2 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CURX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $89.0K |
| Q1 2026 | 8 | $167.6K |
| Q4 2025 | 11 | $140.5K |
| Q3 2025 | 10 | $206.3K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Curanex Pharmaceuticals Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 111,130 | $56.8K | 0.00% | +92,460+495.2% | Added |
| Two Sigma Securities, LLC | 56,651 | $29.0K | 0.00% | +56,651 | New |
| XTX Topco Ltd | 51,289 | $26.2K | 0.00% | +8,904+21.0% | Added |
| Citadel Advisors LLC | 50,559 | $25.9K | 0.00% | −53,719−51.5% | Reduced |
| Two Sigma Investments, LP | 20,254 | $10.4K | 0.00% | −40,848−66.9% | Reduced |
| Citigroup Inc | 19,332 | $9.88K | 0.00% | +19,332 | New |
| Jump Financial, LLC | 10,551 | $5.39K | 0.00% | −6,900−39.5% | Reduced |
| UBS Group AG | 7,995 | $4.08K | 0.00% | −4,996−38.5% | Reduced |
| DRW Securities, LLC | 0 | $0 | 0.00% | −71,553−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,297−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,990−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,378−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −34−100.0% | Sold out |